These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6469294)

  • 21. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 23. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 25. [Toxicity in the current treatment of pulmonary tuberculosis in children].
    Altet Gómez MN; Alcáide Megías J; Boque Genovard MA
    An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?
    Kumar A; Misra PK; Mehotra R; Govil YC; Rana GS
    Am Rev Respir Dis; 1991 Jun; 143(6):1350-2. PubMed ID: 1904700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histopathological and histochemical study of the liver during antituberculotic polychemotherapy in children ].
    Mihailovici MS
    Morphol Embryol (Bucur); 1987; 33(3):205-8. PubMed ID: 2958698
    [No Abstract]   [Full Text] [Related]  

  • 30. An unusual recurrence of antitubercular drug induced hepatotoxicity in a child.
    Bhatia S; Tullu MS; Kannan S; Gogtay NJ; Thatte UM; Lahiri KR
    J Postgrad Med; 2011; 57(2):147-52. PubMed ID: 21654145
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
    Pessayre D; Bentata M; Degott C; Nouel O; Miguet JP; Rueff B; Benhamou JP
    Gastroenterology; 1977 Feb; 72(2):284-9. PubMed ID: 830577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxic hepatitis (liver and antitubercular drugs)].
    Kohan S
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):301-4. PubMed ID: 617560
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
    Türktaş H; Unsal M; Tülek N; Orüç O
    Tuber Lung Dis; 1994 Feb; 75(1):58-60. PubMed ID: 8161767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
    Bartelink AK; Lenders JW; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Tubercle; 1983 Jun; 64(2):125-8. PubMed ID: 6612792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
    Askgaard DS; Wilcke T; Døssing M
    Thorax; 1995 Feb; 50(2):213-4. PubMed ID: 7701468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin].
    Waitzberg VR; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liver damage following antituberculous therapy].
    Thaler H
    Dtsch Med Wochenschr; 1982 Jan; 107(3):113. PubMed ID: 7056159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.